US 12,295,946 B2
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Naveed Shams, Emeryville, CA (US); Henk-Andre Kroon, Emeryville, CA (US); Hisashi Kawata, Osaka (JP); and Noriko Kawabata, Osaka (JP)
Assigned to SANTEN PHARMACEUTICAL CO., LTD., Osaka (JP)
Filed by Santen Pharmaceutical Co., Ltd., Osaka (JP)
Filed on Sep. 11, 2023, as Appl. No. 18/464,646.
Application 18/464,646 is a continuation of application No. 17/521,031, filed on Nov. 8, 2021, granted, now 11,793,798.
Application 17/521,031 is a continuation of application No. 16/887,108, filed on May 29, 2020, granted, now 11,197,849, issued on Dec. 14, 2021.
Application 16/887,108 is a continuation of application No. 16/211,839, filed on Dec. 6, 2018, granted, now 10,702,511, issued on Jul. 7, 2020.
Application 16/211,839 is a continuation of application No. 15/895,100, filed on Feb. 13, 2018, granted, now 10,179,127, issued on Jan. 15, 2019.
Application 15/895,100 is a continuation of application No. 15/212,592, filed on Jul. 18, 2016, granted, now 9,943,510, issued on Apr. 17, 2018.
Application 15/212,592 is a continuation of application No. 14/592,167, filed on Jan. 8, 2015, granted, now 9,415,038, issued on Aug. 16, 2016.
Claims priority of provisional application 61/925,882, filed on Jan. 10, 2014.
Prior Publication US 2024/0000763 A1, Jan. 4, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/444 (2006.01); A61K 9/00 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01)
CPC A61K 31/444 (2013.01) [A61K 9/0048 (2013.01); A61P 27/02 (2018.01); A61P 27/06 (2018.01)] 16 Claims
 
1. A liquid pharmaceutical preparation for lowering of intraocular pressure, comprising 0.002% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl) aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof; and water.